{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:28Z","timestamp":1786980508383,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10072-023-07241-6","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T02:02:08Z","timestamp":1702432928000},"page":"1655-1660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study"],"prefix":"10.1007","volume":"45","author":[{"given":"Simone","family":"Braca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Stornaiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-8319","authenticated-orcid":false,"given":"Cinzia Valeria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"7241_CR1","doi-asserted-by":"publisher","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL (2013) Migraine: the seventh disabler. J Headache Pain 14(1):1. https:\/\/doi.org\/10.1186\/1129-2377-14-1","DOI":"10.1186\/1129-2377-14-1"},{"issue":"4","key":"7241_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1468-2982.1992.1204221.x","volume":"12","author":"BK Rasmussen","year":"1992","unstructured":"Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12(4):221\u2013186. https:\/\/doi.org\/10.1046\/j.1468-2982.1992.1204221.x","journal-title":"Cephalalgia"},{"key":"7241_CR3","doi-asserted-by":"publisher","unstructured":"Lucas C (2021) Migraine with aura. Rev Neurol 177(7):779\u2013784. https:\/\/doi.org\/10.1016\/j.neurol.2021.07.010","DOI":"10.1016\/j.neurol.2021.07.010"},{"issue":"2","key":"7241_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015","journal-title":"Physiol Rev"},{"issue":"3","key":"7241_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/WCO.0b013e32836085f4","volume":"26","author":"A Charles","year":"2013","unstructured":"Charles A (2013) Migraine: a brain state. Curr Opin Neurol 26(3):235\u2013239. https:\/\/doi.org\/10.1097\/WCO.0b013e32836085f4","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"7241_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jcbfm.2010.191","volume":"31","author":"M Lauritzen","year":"2011","unstructured":"Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ (2011) Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 31(1):17\u201335. https:\/\/doi.org\/10.1038\/jcbfm.2010.191","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"7241_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","volume":"17","author":"A Charles","year":"2018","unstructured":"Charles A (2018) The pathophysiology of migraine: implications for clinical management. The Lancet Neurology 17(2):174\u2013182. https:\/\/doi.org\/10.1016\/S1474-4422(17)30435-0","journal-title":"The Lancet Neurology"},{"issue":"12","key":"7241_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/01.wnr.0000175250.33159.a9","volume":"16","author":"S Akerman","year":"2005","unstructured":"Akerman S, Goadsby PJ (2005) Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. NeuroReport 16(12):1383\u20131387. https:\/\/doi.org\/10.1097\/01.wnr.0000175250.33159.a9","journal-title":"NeuroReport"},{"issue":"3","key":"7241_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.2001.81.3.1065","volume":"81","author":"GG Somjen","year":"2001","unstructured":"Somjen GG (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 81(3):1065\u20131096. https:\/\/doi.org\/10.1152\/physrev.2001.81.3.1065","journal-title":"Physiol Rev"},{"key":"7241_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fneur.2018.00019","volume":"9","author":"O Cozzolino","year":"2018","unstructured":"Cozzolino O, Marchese M, Trovato F, Pracucci E, Ratto GM, Buzzi MG, Sicca F, Santorelli FM (2018) Understanding spreading depression from headache to sudden unexpected death. Front Neurol 9:19. https:\/\/doi.org\/10.3389\/fneur.2018.00019","journal-title":"Front Neurol"},{"issue":"3","key":"7241_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00221-022-06307-9","volume":"240","author":"AA Mathew","year":"2022","unstructured":"Mathew AA, Panonnummal R (2022) Cortical spreading depression: culprits and mechanisms. Exp Brain Res 240(3):733\u2013749. https:\/\/doi.org\/10.1007\/s00221-022-06307-9","journal-title":"Exp Brain Res"},{"key":"7241_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/164_2018_201","volume":"255","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L (2019) Role of CGRP in migraine. Handb Exp Pharmacol 255:121\u2013130. https:\/\/doi.org\/10.1007\/164_2018_201","journal-title":"Handb Exp Pharmacol"},{"key":"7241_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2018.04.025","volume":"382","author":"L Jiang","year":"2018","unstructured":"Jiang L, Wang Y, Xu Y, Ma D, Wang M (2018) The transient receptor potential ankyrin type 1 plays a critical role in cortical spreading depression. Neuroscience 382:23\u201334. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.04.025","journal-title":"Neuroscience"},{"issue":"46","key":"7241_CR14","doi-asserted-by":"publisher","first-page":"18985","DOI":"10.1073\/pnas.1215435109","volume":"109","author":"A Tozzi","year":"2012","unstructured":"Tozzi A, de Iure A, Di Filippo M, Costa C, Caproni S, Pisani A, Bonsi P, Picconi B, Cupini LM, Materazzi S, Geppetti P, Sarchielli P, Calabresi P (2012) Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc Natl Acad Sci USA 109(46):18985\u201318990. https:\/\/doi.org\/10.1073\/pnas.1215435109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"7241_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0333102417735845","volume":"39","author":"A Filiz","year":"2019","unstructured":"Filiz A, Tepe N, Eftekhari S, Boran HE, Dilekoz E, Edvinsson L, Bolay H (2019) CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior. Cephalalgia 39(3):354\u2013365. https:\/\/doi.org\/10.1177\/0333102417735845","journal-title":"Cephalalgia"},{"issue":"3","key":"7241_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/0333102418774299","volume":"39","author":"LN Close","year":"2019","unstructured":"Close LN, Eftekhari S, Wang M, Charles AC, Russo AF (2019) Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia 39(3):428\u2013434. https:\/\/doi.org\/10.1177\/0333102418774299","journal-title":"Cephalalgia"},{"issue":"7","key":"7241_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/0333102421989601","volume":"41","author":"K Drellia","year":"2021","unstructured":"Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD (2021) Anti-CGRP monoclonal antibodies for migraine prevention: a systematic review and likelihood to help or harm analysis. Cephalalgia 41(7):851\u2013864. https:\/\/doi.org\/10.1177\/0333102421989601","journal-title":"Cephalalgia"},{"key":"7241_CR18","doi-asserted-by":"publisher","unstructured":"Vernieri F, Altamura C, Brunelli N, Costa CM, Aurilia C, Egeo G, Fofi L, Favoni V, Pierangeli G, Lovati C, Aguggia M, d'Onofrio F, Doretti A, Di Fiore P, Finocchi C, Rao R, Bono F, Ranieri A, Albanese M, Cevoli S, Barbanti P, GARLIT Study Group (2021) Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study). J Headache Pain 22(1):35. https:\/\/doi.org\/10.1186\/s10194-021-01247-1","DOI":"10.1186\/s10194-021-01247-1"},{"issue":"1","key":"7241_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-022-01415-x","volume":"23","author":"MT Driessen","year":"2022","unstructured":"Driessen MT, Cohen JM, Thompson SF, Patterson-Lomba O, Seminerio MJ, Carr K, Totev TI, Sun R, Yim E, Mu F, Ayyagari R (2022) Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine. J Headache Pain 23(1):56. https:\/\/doi.org\/10.1186\/s10194-022-01415-x","journal-title":"J Headache Pain"},{"issue":"1","key":"7241_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s10194-022-01433-9","volume":"23","author":"CK Cullum","year":"2022","unstructured":"Cullum CK, Do TP, Ashina M, Bendtsen L, Hugger SS, Iljazi A, Gusatovic J, Snellman J, Lopez-Lopez C, Ashina H, Amin FM (2022) Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study. J Headache Pain 23(1):61. https:\/\/doi.org\/10.1186\/s10194-022-01433-9","journal-title":"J Headache Pain"},{"issue":"6","key":"7241_CR21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/head.14528","volume":"63","author":"F Sacc\u00e0","year":"2023","unstructured":"Sacc\u00e0 F, Braca S, Sansone M, Miele A, Stornaiuolo A, De Simone R, Russo CV (2023) A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine. Headache 63(6):788\u2013794. https:\/\/doi.org\/10.1111\/head.14528","journal-title":"Headache"},{"key":"7241_CR22","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"6 Suppl 1","key":"7241_CR23","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/wnl.56.suppl_1.s20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20\u2013S28. https:\/\/doi.org\/10.1212\/wnl.56.suppl_1.s20","journal-title":"Neurology"},{"issue":"11","key":"7241_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrneurol.2013.192","volume":"9","author":"AC Charles","year":"2013","unstructured":"Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9(11):637\u2013644. https:\/\/doi.org\/10.1038\/nrneurol.2013.192","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"7241_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1152\/physrev.00027.2014","volume":"95","author":"C Ayata","year":"2015","unstructured":"Ayata C, Lauritzen M (2015) Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiol Rev 95(3):953\u2013993. https:\/\/doi.org\/10.1152\/physrev.00027.2014","journal-title":"Physiol Rev"},{"key":"7241_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2013.09.002","volume":"253","author":"A Shatillo","year":"2013","unstructured":"Shatillo A, Koroleva K, Giniatullina R, Naumenko N, Slastnikova AA, Aliev RR, Bart G, Atalay M, Gu C, Khazipov R, Davletov B, Grohn O, Giniatullin R (2013) Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system. Neuroscience 253:341\u2013349. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.09.002","journal-title":"Neuroscience"},{"issue":"1","key":"7241_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10194-019-0978-z","volume":"20","author":"L Jiang","year":"2019","unstructured":"Jiang L, Ma D, Grubb BD, Wang M (2019) ROS\/TRPA1\/CGRP signaling mediates cortical spreading depression. J Headache Pain 20(1):25. https:\/\/doi.org\/10.1186\/s10194-019-0978-z","journal-title":"J Headache Pain"},{"issue":"6","key":"7241_CR28","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s00415-021-10546-1","volume":"268","author":"E Matteo","year":"2021","unstructured":"Matteo E, Pensato U, Favoni V, Giannini G, Pierangeli G, Cevoli S (2021) Do anti-CGRP drugs have a role in migraine aura therapy? J Neurol 268(6):2273\u20132274. https:\/\/doi.org\/10.1007\/s00415-021-10546-1","journal-title":"J Neurol"},{"issue":"5","key":"7241_CR29","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/jcm11051228","volume":"11","author":"M Albanese","year":"2022","unstructured":"Albanese M, Mercuri NB (2022) Could the new anti-CGRP monoclonal antibodies be effective in migraine aura? Case reports and literature review. J Clin Med 11(5):1228. https:\/\/doi.org\/10.3390\/jcm11051228","journal-title":"J Clin Med"},{"issue":"1","key":"7241_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s10194-023-01656-4","volume":"24","author":"HM Al-Khazali","year":"2023","unstructured":"Al-Khazali HM, Ashina H, Wiggers A, Rose K, Iljazi A, Christensen RH, Schytz HW, Amin FM, Ashina M (2023) Calcitonin gene-related peptide causes migraine aura. J Headache Pain 24(1):124. https:\/\/doi.org\/10.1186\/s10194-023-01656-4","journal-title":"J Headache Pain"},{"issue":"4","key":"7241_CR31","doi-asserted-by":"publisher","first-page":"333102423116180","DOI":"10.1177\/03331024231161809","volume":"43","author":"CV Russo","year":"2023","unstructured":"Russo CV, Sacc\u00e0 F, Braca S, Sansone M, Miele A, Stornaiuolo A, De Simone R (2023) Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study. Cephalalgia 43(4):3331024231161809. https:\/\/doi.org\/10.1177\/03331024231161809","journal-title":"Cephalalgia"},{"issue":"5","key":"7241_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/j.pain.0000000000001791","volume":"161","author":"A Melo-Carrillo","year":"2020","unstructured":"Melo-Carrillo A, Schain AJ, Stratton J, Strassman AM, Burstein R (2020) Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier. Pain 161(5):1037\u20131043. https:\/\/doi.org\/10.1097\/j.pain.0000000000001791","journal-title":"Pain"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07241-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T03:27:36Z","timestamp":1710473256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7241"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07241-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved at our local ethics committee and all patients gave written informed consent before any procedure linked to the study. The study conforms with World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and patient consent"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: CVR received personal compensation from Sanofi Genzyme, Eli Lilly and Merck Serono. SB and RDS received personal compensation from Lilly for oral presentations. AM, AS and GC declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting interests"}}]}}